selected publications
-
academic article
- A virtual community-of-practice approach by rural stakeholders in managing pneumoconiosis in the USA: a cross-sectional analysis.. Rural and remote health. 20:-. 2020
- Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trials.. Leukemia & lymphoma. 59:1624-1633. 2018
- MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study.. Leukemia. :-. 2016
- Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. 2015
- Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232.. Blood. :-. 2015
- A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 2015
- Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.. Nature communications. 6:-. 2015
- Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
- SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia.. Blood. 121:148-155. 2013
- Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.. Blood. 121:485-488. 2013
- ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30:751-757. 2012
- Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.. Blood. 119:1872-1881. 2012
- Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.. Cancer cell. 22:153-166. 2012
- Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.. Blood. 120:4197-4204. 2012
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.. Blood. 119:3512-3522. 2012
- Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.. Nature genetics. 43:237-241. 2011
- Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.. Blood. 118:3080-3087. 2011
- Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.. Blood. 115:1394-1405. 2010
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.. Blood. 116:4874-4884. 2010
- Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.. Blood. 115:5312-5321. 2010
- Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.. The New England journal of medicine. 360:470-480. 2009
- Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.. JAMA. 301:393-403. 2009
- Germline genomic variants associated with childhood acute lymphoblastic leukemia.. Nature genetics. 41:1001-1005. 2009
- JAK mutations in high-risk childhood acute lymphoblastic leukemia.. Proceedings of the National Academy of Sciences of the United States of America. 106:9414-9418. 2009
- Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.. Nature genetics. 41:1243-1246. 2009
- Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected].. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26:4376-4384. 2008